The Global Single-use Bioprocessing Systems Market Is Witnessing High Growth

 

The single-use bioprocessing systems market is a rapidly growing industry that is expected to reach $8.5 billion by 2025. This market is driven by the increasing demand for biopharmaceuticals and the need for cost-effective and efficient production methods.

Single-use bioprocessing systems, also known as disposable bioprocessing systems, are designed for one-time use and are typically made of plastic or other non-reusable materials. They are used in the production of biopharmaceuticals, including vaccines, monoclonal antibodies, and other protein-based drugs.

One of the main advantages of single-use bioprocessing systems is that they reduce the risk of cross-contamination and minimize the need for cleaning and sterilization. This not only saves time and money, but also ensures product purity and safety. Additionally, single-use systems are more flexible and can be easily scaled up or down, making them ideal for small-scale or large-scale production.

The Single-use Bioprocessing Systems Market is segmented into several categories, including consumables, equipment, and services. Consumables include bags, tubing, filters, and other disposable items that are used in the production process. Equipment includes bioreactors, mixers, and other devices that are used to control the conditions in the production process. Services include training, installation, and maintenance of the systems.

Some of the key players in the single-use bioprocessing systems market include Thermo Fisher Scientific, Merck Millipore, Sartorius, GE Healthcare, and Eppendorf.

Overall, the single-use bioprocessing systems market is expected to continue growing as the demand for biopharmaceuticals increases and more companies adopt these systems for their production processes.

A disposable bioprocessing system is one in which systems such as disposable bioreactors, single-use bags, and disposable filters are discarded after use rather than cleaned or sterilised. Single-use systems are widely used in upstream and downstream bioprocessing due to their advantages over conventional bioprocessing systems, which include lower costs, faster implementation, and less risk of cross-contamination. Furthermore, rising adoption of single-use bioprocessing systems, increased investment in R&D by various government and private organisations, rising demand for single-use systems in the biopharmaceutical sector, and an increasing number of key players offering technologically advanced bioprocessing products are expected to drive the growth of the single-use bioprocessing systems market over the forecast period.

Key Players

Compagnie de Saint-Gobain S.A., Thermo Fisher Scientific Inc., Applikon Biotechnology BV, Parker-Hannifin Corporation, Sartorius AG, Eppendorf AG, Danaher Corporation, Merck KGaA, and General Electric Company are key players in the single-use bioprocessing systems market.